Come and join us across the globe
 Founded by Pr. Jacques Moret 
Sign In

Shaping the Future of Flow Diversion: The Promise of Surface Modification Technology (HPC)

Last update on November 16, 2026

Surface modification is opening new perspectives in flow diversion, particularly for patients in whom dual antiplatelet therapy (DAPT) may be challenging. In this LINNC Online webinar, Laurent Spelle, Laurent Pierot, Markus Holtmannspötter and Jean-Christophe Gentric review the latest evidence supporting the use of a surface-modified flow diverter, discuss real-world clinical applications of HPC technology, and explore how antiplatelet management may evolve in the future.

Key takeaways

  • The COATING trial demonstrated comparable safety and efficacy between an HPC-coated flow diverter used with single antiplatelet therapy (SAPT) and a bare flow diverter used with DAPT.
  • HPC technology may offer valuable treatment options in selected patients requiring anticoagulation or presenting with complex clinical situations.
  • Current evidence supports a more individualised approach to antiplatelet therapy rather than a universal shift from DAPT to SAPT.
  • Surface modification could extend beyond flow diversion and influence the development of future endovascular devices.

 

EXPERTS

 

Laurent
Spelle
Paris,
France

Laurent Spelle

Moderator

 

Markus Holtmannspotter
Nürnberg,
Germany

Markus Holtmannspotter

Speaker

 

Laurent
Pierot
Reims,
France

Laurent Pierot

Speaker

Jean-Christophe Gentric
Brest,
France

Jean-Christophe Gentric

Speaker

 

This program is supported by

Wallaby Phenox
On the same subject
Come and join us across the globe
 Founded by Pr. Jacques Moret